REINFUSION AND SERIAL MEASUREMENTS OF CARBOPLATIN-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS RECEIVING MULTIPLE CYCLES OF HIGH-DOSE CHEMOTHERAPY

被引：27

作者：

SHEA, TC

MASON, JR

BRESLIN, M

BISSENT, E

MULLEN, M

TAETLE, R

机构：

[1] UNIV N CAROLINA, CHAPEL HILL, NC USA

[2] UNIV CALIF SAN DIEGO, SAN DIEGO, CA 92103 USA

[3] UNIV ARIZONA, CTR CANC, PHOENIX, AZ USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1994年 / 12卷 / 05期

关键词：

D O I：

10.1200/JCO.1994.12.5.1012

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1012 / 1020

页数：9

共 36 条

[1] ADVANCED BREAST-CANCER - HIGH-DOSE CHEMOTHERAPY AND BONE-MARROW AUTO-TRANSPLANTS [J].

ANTMAN, K ;

GALE, RP .

ANNALS OF INTERNAL MEDICINE, 1988, 108 (04) :570-574

[2] AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH RELAPSED HODGKINS-DISEASE [J].

ARMITAGE, JO ;

BIERMAN, PJ ;

VOSE, JM ;

ANDERSON, JR ;

WEISENBURGER, DD ;

KESSINGER, A ;

REED, EC ;

VAUGHAN, WP ;

COCCIA, PF ;

PURTILO, DT .

AMERICAN JOURNAL OF MEDICINE, 1991, 91 (06) :605-611

[3] AUTOLOGOUS BONE-MARROW TRANSPLANTATION - CURRENT STATUS AND FUTURE-DIRECTIONS [J].

CHESON, BD ;

LACERNA, L ;

LEYLANDJONES, B ;

SAROSY, G ;

WITTES, RE .

ANNALS OF INTERNAL MEDICINE, 1989, 110 (01) :51-65

[4]

CHOU NJ, 1993, BLOOD, V81, P2031

[5]

DOUER D, 1993, P AN M AM SOC CLIN, V12, P62

[6] TREATMENT OF ESTROGEN RECEPTOR-NEGATIVE OR HORMONALLY REFRACTORY BREAST-CANCER WITH DOUBLE HIGH-DOSE CHEMOTHERAPY INTENSIFICATION AND BONE-MARROW SUPPORT [J].

DUNPHY, FR ;

SPITZER, G ;

BUZDAR, AU ;

HORTOBAGYI, GN ;

HORWITZ, LJ ;

YAU, JC ;

SPINOLO, JA ;

JAGANNATH, S ;

HOLMES, F ;

WALLERSTEIN, RO ;

BOHANNAN, PA ;

DICKE, KA .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (07) :1207-1216

[7]

ELIAS AD, 1992, BLOOD, V79, P3036

[8]

FENNELLY D, 1993, AM SOC CLIN ONCOL, V12, P260

[9] BONE-MARROW AUTO-TRANSPLANTATION FOR SOLID TUMORS - PROSPECTS [J].

FREI, E ;

ANTMAN, K ;

TEICHER, B ;

EDER, P ;

SCHNIPPER, L .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (04) :515-526

[10] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR OR GRANULOCYTE COLONY-STIMULATING FACTOR INFUSION MAKES HIGH-DOSE ETOPOSIDE A SAFE OUTPATIENT REGIMEN THAT IS EFFECTIVE IN LYMPHOMA AND MYELOMA PATIENTS [J].

GIANNI, AM ;

BREGNI, M ;

SIENA, S ;

MAGNI, M ;

DINICOLA, M ;

LOMBARDI, F ;

TARELLA, C ;

PILERI, A ;

BONADONNA, G .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (12) :1955-1962

← 1 2 3 4 →